Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia. (Q38167332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Pauline Y Huang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Larissa Belov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Zadie A Davis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Aneela Majid

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Stephen P Mulligan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Richard I Christopherson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

24 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

2085-2092

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24289109%20AND%20SRC:MED&resulttype=core&format=json

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

B-CLL: is the enigma of disease heterogeneity about to be revealed?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

A clinical staging system for chronic lymphocytic leukemia: prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Diagnostic issues in chronic lymphocytic leukaemia (CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Surface profiles for subclassification of chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

An extended antibody microarray for surface profiling metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Identification of repertoires of surface antigens on leukemias using an antibody microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Assessment and optimisation of normalisation methods for dual-colour antibody microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Adhesion molecules controlling lymphocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

The CD40 antigen and its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Resistance to cytotoxic chemotherapy is induced by NK cells in non-Hodgkin's Lymphoma Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Plasma cell generation from B-lymphocytes via CD27/CD70 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

21 January 2018

New B-cell CD molecules.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

BTLA and HVEM cross talk regulates inhibition and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

Differential expression of CD180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.867486